Girgis Obaid

Assistant Professor - Bioengineering

Dr. Girgis Obaid's lab integrates nanotechnology, immunoengineering and light-activated “photodynamic” therapy to develop new ways to treat stubborn pancreas cancer and cancers of the head and neck. Dr. Obaid's research is supported by the NIH, NSF and CPRIT.

+1 (972) 883 - 7375
BSB15.510
Obaid Lab Research
Obaid Lab Team
ORCID

About Girgis Obaid

Publications

Recent strides in macromolecular targeted photodynamic therapy for cancer 2024 - Journal Article

A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin–Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes 2024 - Journal Article

Engineering photodynamics for treatment, priming and imaging 2024 - Journal Article

A single photodynamic priming protocol augments delivery of ⍺‐PD‐L1 mAbs and induces immunogenic cell death in head and neck tumors 2024 - Journal Article

Establishing a Robust and Reliable Response from a Potent Osmium‐Based Photosensitizer Via Lipid Nanoformulation† 2023 - Journal Article

Enabling In Vivo Optical Imaging of an Osmium Photosensitizer by Micellar Formulation 2022 - Journal Article

Deep-Tissue Activation of Photonanomedicines: An Update and Clinical Perspectives 2022 - Journal Article

Remediating Desmoplasia with EGFR‐Targeted Photoactivable Multi‐Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer 2022 - Journal Article